A. Sarper Diler

589 total citations
22 papers, 465 citations indexed

About

A. Sarper Diler is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, A. Sarper Diler has authored 22 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Immunology. Recurrent topics in A. Sarper Diler's work include Neuroscience and Neuropharmacology Research (6 papers), T-cell and B-cell Immunology (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). A. Sarper Diler is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), T-cell and B-cell Immunology (4 papers) and Nicotinic Acetylcholine Receptors Study (3 papers). A. Sarper Diler collaborates with scholars based in Türkiye, France and United States. A. Sarper Diler's co-authors include Y.Ziya Ziylan, Gülay Üzüm, Fatma Savran Oğuz, Pierre‐Antoine Gourraud, Mahmut Çarin, Derek Middleton, A. Meenagh, C. Sleator, M. Tevfik Dorak and Sevgi Kalayoğlu Beşışık and has published in prestigious journals such as Blood, Life Sciences and Pharmacological Research.

In The Last Decade

A. Sarper Diler

21 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Sarper Diler Türkiye 14 214 103 85 48 46 22 465
Bobbak Mansouri United States 12 341 1.6× 42 0.4× 105 1.2× 74 1.5× 87 1.9× 21 587
Maria Grazia Piccinno Italy 10 161 0.8× 42 0.4× 58 0.7× 35 0.7× 48 1.0× 15 471
Robert Graham Quinton Leslie Denmark 12 266 1.2× 36 0.3× 122 1.4× 24 0.5× 34 0.7× 19 538
John S. Dallas United States 16 135 0.6× 38 0.4× 228 2.7× 82 1.7× 14 0.3× 28 757
J Lokaj Czechia 16 376 1.8× 62 0.6× 96 1.1× 37 0.8× 10 0.2× 40 652
Makoto Nakamura Japan 11 48 0.2× 118 1.1× 82 1.0× 20 0.4× 40 0.9× 43 371
M Torboli Italy 3 176 0.8× 30 0.3× 124 1.5× 35 0.7× 9 0.2× 3 618
A Jones United States 10 298 1.4× 27 0.3× 154 1.8× 14 0.3× 45 1.0× 13 652
G Boccoli Italy 15 277 1.3× 114 1.1× 192 2.3× 41 0.9× 12 0.3× 22 850
Elisabeth Legrand France 11 90 0.4× 75 0.7× 85 1.0× 126 2.6× 8 0.2× 20 442

Countries citing papers authored by A. Sarper Diler

Since Specialization
Citations

This map shows the geographic impact of A. Sarper Diler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Sarper Diler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Sarper Diler more than expected).

Fields of papers citing papers by A. Sarper Diler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Sarper Diler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Sarper Diler. The network helps show where A. Sarper Diler may publish in the future.

Co-authorship network of co-authors of A. Sarper Diler

This figure shows the co-authorship network connecting the top 25 collaborators of A. Sarper Diler. A scholar is included among the top collaborators of A. Sarper Diler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Sarper Diler. A. Sarper Diler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ören, Meryem Merve, et al.. (2021). Is there a relationship between ACTN3 R577X gene polymorphism and sarcopenia?. Aging Clinical and Experimental Research. 34(4). 757–765. 3 indexed citations
2.
Diler, A. Sarper, Y.Ziya Ziylan, & Gülay Üzüm. (2013). N-methyl-D-aspartate Receptors Are Involved in Caffeine-Induced Facilitation on Memory Retention of Passive Avoidance Learning in Rats. 3(4). 169–174. 5 indexed citations
3.
Middleton, Derek, A. Sarper Diler, A. Meenagh, C. Sleator, & Pierre‐Antoine Gourraud. (2009). Killer immunoglobulin‐like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA‐C1 group) protect against chronic myeloid leukaemia. Tissue Antigens. 73(6). 553–560. 49 indexed citations
4.
Öztürk, Şükrü, Kıvanç Çefle, Şükrü Palanduz, et al.. (2008). Effect of Cyclosporin A and Tacrolimus on Sister Chromatid Exchange Frequency in Renal Transplant Patients. Genetic Testing. 12(3). 427–430. 14 indexed citations
5.
Diler, A. Sarper, et al.. (2007). Sex differences in modulating blood brain barrier permeability by NO in pentylenetetrazol-induced epileptic seizures. Life Sciences. 80(14). 1274–1281. 10 indexed citations
6.
Spyropoulou‐Vlachou, Maria, Kanjaksha Ghosh, Aruna Pawar, et al.. (2007). 14th International HLA and Immunogenetics Workshop: Report from the reproductive immunology component. Tissue Antigens. 69(s1). 297–303. 21 indexed citations
7.
Middleton, Derek, A. Meenagh, C. Sleator, et al.. (2007). No association of KIR genes with Behcet’s disease. Tissue Antigens. 70(5). 435–438. 27 indexed citations
8.
Ak, Gülsüm, et al.. (2006). HLA Antigens in erosive oral lichen planus.
9.
Üzüm, Gülay, et al.. (2005). NITRIC OXIDE INVOLVEMENT IN SEIZURES ELICITED BY PENTYLENTETRAZOL AND SEX DEPENDENCE. International Journal of Neuroscience. 115(11). 1502–1514. 16 indexed citations
10.
Ziylan, Y.Ziya, A. Sarper Diler, Jeanne-Marie Lefauconnier, & Jean‐Marie Bourre. (2005). EVIDENCE FOR ASCORBIC ACID TRANSPORT SYSTEM IN RAT BRAIN CAPILLARIES. International Journal of Neuroscience. 116(1). 25–38. 7 indexed citations
11.
Üzüm, Gülay, et al.. (2005). Erythropoietin prevents the increase in blood–brain barrier permeability during pentylentetrazol induced seizures. Life Sciences. 78(22). 2571–2576. 54 indexed citations
12.
Üzüm, Gülay, et al.. (2004). TOLERANCE TO PENTYLENTETRAZOL-INDUCED CONVULSIONS AND PROTECTION OF CEREBROVASCULAR INTEGRITY BY CHRONIC NICOTINE. International Journal of Neuroscience. 114(6). 735–748. 5 indexed citations
13.
Üzüm, Gülay, et al.. (2004). NICOTINE IMPROVES LEARNING AND MEMORY IN RATS: MORPHOLOGICAL EVIDENCE FOR ACETYLCHOLINE INVOLVEMENT. International Journal of Neuroscience. 114(9). 1163–1179. 18 indexed citations
14.
Oğuz, Fatma Savran, Lale Öçal, A. Sarper Diler, et al.. (2004). HLA B‐27 Subtypes in Turkish Patients with Spondyloarthropathy and Healthy Controls. Disease Markers. 20(6). 309–312. 23 indexed citations
15.
Oğuz, Fatma Savran, Sevgi Kalayoğlu Beşışık, A. Sarper Diler, et al.. (2003). HLA system affects the age‐at‐onset in chronic myeloid leukemia. American Journal of Hematology. 73(4). 256–262. 22 indexed citations
16.
17.
Dorak, M. Tevfik, Fatma Savran Oğuz, Nevin Yalman, et al.. (2002). A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL. Leukemia Research. 26(7). 651–656. 39 indexed citations
18.
Arnaiz‐Villena, A., Eduardo Gómez-Casado, J. Moscoso, et al.. (2001). HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans. Tissue Antigens. 57(4). 308–317. 88 indexed citations
19.
Üzüm, Gülay, A. Sarper Diler, & Y.Ziya Ziylan. (1999). CHRONIC NICOTINE PRETREATMENT PROTECTS THE BLOOD–BRAIN BARRIER AGAINST NICOTINE-INDUCED SEIZURES IN THE RAT. Pharmacological Research. 40(3). 263–269. 15 indexed citations
20.
Ziylan, Y.Ziya, et al.. (1993). Changes in the permeability of the blood-brain barrier in acute hyperammonemia. Molecular and Chemical Neuropathology. 20(3). 203–218. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026